Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• ShipitsinMCampbellLLArganiPMolecular definition of breast tumor heterogeneityCancer cell200711325927317349583
   PubMed Web of Science ®Google Scholar
• ChambersAFGroomACMacDonaldICDissemination and growth of cancer cells in metastatic sitesNat Rev Cancer20022856357212154349
   PubMed Web of Science ®Google Scholar
• ReyaTMorrisonSJClarkeMFWeissmanILStem cells, cancer, and cancer stem cellsNature2001414685910511111689955
   PubMed Web of Science ®Google Scholar
• EylerCERichJNSurvival of the fittest: cancer stem cells in therapeutic resistance and angiogenesisJ Clin Oncol200826172839284518539962
   PubMed Web of Science ®Google Scholar
• DickJEBreast cancer stem cells revealedProc Natl Acad Sci U S A200310073547354912657737
   PubMed Web of Science ®Google Scholar
• CampbellLLPolyakKBreast tumor heterogeneity: cancer stem cells or clonal evolution?Cell Cycle20076192332233817786053
   PubMed Web of Science ®Google Scholar
• AllottEHGeradtsJSunXIntratumoral heterogeneity as a source of discordance in breast cancer biomarker classificationBreast Cancer Res20161816827349894
   PubMed Web of Science ®Google Scholar
• Al-HajjMWichaMSBenito-HernandezAMorrisonSJClarkeMFProspective identification of tumorigenic breast cancer cellsProc Natl Acad Sci U S A200310073983398812629218
   PubMed Web of Science ®Google Scholar
• FuhrJEFryeAKattineAAVan MeterSFlow cytometric determination of breast tumor heterogeneityCancer1991675140114051846776
   PubMed Web of Science ®Google Scholar
• MichorFPolyakKThe origins and implications of intratumor heterogeneityCancer Prev Res (Phila)20103111361136420959519
   PubMed Web of Science ®Google Scholar
• NowellPCThe clonal evolution of tumor cell populationsScience197619442602328959840
   PubMed Web of Science ®Google Scholar
• StinglJCaldasCMolecular heterogeneity of breast carcinomas and the cancer stem cell hypothesisNat Rev Cancer200771079179917851544
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• CreightonCJGibbonsDLKurieJMThe role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspectiveCancer Manag Res2013518719523986650
   PubMedGoogle Scholar
• TsaiJHYangJEpithelial–mesenchymal plasticity in carcinoma metastasisGenes Dev201327202192220624142872
   PubMed Web of Science ®Google Scholar
• TsaiJHDonaherJLMurphyDAChauSYangJSpatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasisCancer Cell201222672573623201165
   PubMed Web of Science ®Google Scholar
• YangMHImraliAHeeschenCCirculating cancer stem cells: the importance to selectChin J Cancer Res201527543744926543330
   PubMed Web of Science ®Google Scholar
• AlmendroVKimHJChengYKGenetic and phenotypic diversity in breast tumor metastasesCancer Res20147451338134824448237
   PubMed Web of Science ®Google Scholar
• BuchlerPReberHARothMMShiroishiMFriessHHinesOJTarget therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancerNeoplasia20079211912717356708
   PubMed Web of Science ®Google Scholar
• QuailDFJoyceJAMicroenvironmental regulation of tumor progression and metastasisNat Med201319111423143724202395
   PubMed Web of Science ®Google Scholar
• KimJBSteinRO’HareMJThree-dimensional in vitro tissue culture models of breast cancer – a reviewBreast Cancer Res Treat200485328129115111767
   PubMed Web of Science ®Google Scholar
• AkasovRZaytseva-ZotovaDBurovSFormation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitroInt J Pharm20165061–214815727107900
   PubMed Web of Science ®Google Scholar
• MikhailASEetezadiSAllenCMulticellular tumor spheroids for evaluation of cytotoxicity and tumor growth inhibitory effects of nanomedicines in vitro: a comparison of docetaxel-loaded block copolymer micelles and Taxotere(R)Plos One201384e6263023626842
   PubMed Web of Science ®Google Scholar
• LaBarberaDVReidBGYooBHThe multicellular tumor spheroid model for high-throughput cancer drug discoveryExpert Opin Drug Discov20127981983022788761
   PubMed Web of Science ®Google Scholar
• EdmondsonRBroglieJJAdcockAFYangLThree-dimensional cell culture systems and their applications in drug discovery and cell-based biosensorsAssay Drug Dev Technol201412420721824831787
   PubMed Web of Science ®Google Scholar
• HaycockJW3D cell culture: a review of current approaches and techniquesMethods Mol Biol201169511521042962
   PubMedGoogle Scholar
• LinRZChangHYRecent advances in three-dimensional multicellular spheroid culture for biomedical researchBiotechnol J200839–101172118418566957
   PubMedGoogle Scholar
• CarverKMingXJulianoRLMulticellular tumor spheroids as a model for assessing delivery of oligonucleotides in three dimensionsMol Ther Nucleic Acids20143e15324618852
   PubMedGoogle Scholar
• HorningJLSahooSKVijayaraghavaluS3-D tumor model for in vitro evaluation of anticancer drugsMol Pharm20085584986218680382
   PubMed Web of Science ®Google Scholar
• KunjithapathamRKarthikeyanSGeschwindJFReversal of anchorage-independent multicellular spheroid into a monolayer mimics a metastatic modelSci Rep20144681625351825
   PubMed Web of Science ®Google Scholar
• RaghavanSMehtaPHorstENWardMRRowleyKRMehtaGComparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicityOncotarget2016713169481696126918944
   PubMedGoogle Scholar
• MehtaGHsiaoAYIngramMLukerGDTakayamaSOpportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacyJ Control Release2012164219220422613880
   PubMed Web of Science ®Google Scholar
• CorreiaALBissellMJThe tumor microenvironment is a dominant force in multidrug resistanceDrug Resist Updat2012151–2394922335920
   PubMed Web of Science ®Google Scholar
• BurlesonKMCaseyRCSkubitzKMPambuccianSEOegemaTRJrSkubitzAPOvarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayersGynecol Oncol200493117018115047232
   PubMed Web of Science ®Google Scholar
• VinciMBoxCEcclesSAThree-dimensional (3D) tumor spheroid invasion assayJ Vis Exp201599e5268625993495
   PubMed Web of Science ®Google Scholar
• FriedrichJSeidelCEbnerRKunz-SchughartLASpheroid-based drug screen: considerations and practical approachNat Protoc20094330932419214182
   PubMed Web of Science ®Google Scholar
• HirschhaeuserFMenneHDittfeldCWestJMueller-KlieserWKunz-SchughartLAMulticellular tumor spheroids: an underestimated tool is catching up againJ Biotechnol2010148131520097238
   PubMed Web of Science ®Google Scholar
• AsgharWEl AssalRShafieeHPitteriSPaulmuruganRDemirciUEngineering cancer microenvironments for in vitro 3-D tumor modelsMater Today20151810539553
   Web of Science ®Google Scholar
• IvanovDPParkerTLWalkerDAMultiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheresPlos One201498
   Web of Science ®Google Scholar
• SalmenperaPKankuriEBizikJFormation and activation of fibroblast spheroids depend on fibronectin-integrin interactionExp Cell Res2008314193444345218824166
   PubMed Web of Science ®Google Scholar
• JooSHCyclic peptides as therapeutic agents and biochemical toolsBiomol Ther (Seoul)2012201192624116270
   PubMed Web of Science ®Google Scholar
• MaguireSLPeckBWaiPTThree-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 modelJ Pathol2016240331532827512948
   PubMed Web of Science ®Google Scholar
• Pacheco-MarinRMelendez-ZajglaJCastillo-RojasGTranscriptome profile of the early stages of breast cancer tumoral spheroidsSci Rep201662337327021602
   PubMed Web of Science ®Google Scholar
• LiQChenCYKapadiaA3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screenJ Biomol Screen201116214115421297102
   PubMedGoogle Scholar
• BalachanderGMBalajiSARangarajanAChatterjeeKEnhanced metastatic potential in a 3D tissue scaffold toward a comprehensive in vitro model for breast cancer metastasisAcs Appl Mater Inter20157502781027822
   Web of Science ®Google Scholar
• AkasovRHaqSHaxhoFSialylation transmogrifies human breast and pancreatic cancer cells into 3D multicellular tumor spheroids using cyclic RGD-peptide induced self-assemblyOncotarget2016740661196613427608845
   PubMedGoogle Scholar
• TanMYaoJYuDOverexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilitiesCancer Res1997576119912059067293
   PubMed Web of Science ®Google Scholar
• HaxhoFNeufeldRJSzewczukMRNeuraminidase-1: a novel therapeutic target in multistage tumorigenesisOncotarget2016726408604088127029067
   PubMedGoogle Scholar
• Canadian Cancer Statistics Advisory CommitteeCanadian Cancer Statistics 2015Toronto, ONCanadian Cancer Society2015
   Google Scholar
• CaoLZhouYZhaiBSphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell linesBMC Gastroenterol2011117121669008
   PubMed Web of Science ®Google Scholar
• LiYRogoffHAKeatesSSuppression of cancer relapse and metastasis by inhibiting cancer stemnessProc Natl Acad Sci U S A201511261839184425605917
   PubMed Web of Science ®Google Scholar
• SoriaGOfri-ShahakMHaasIInflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transitionBMC Cancer201111113021486440
   PubMed Web of Science ®Google Scholar
• PikarskyEPoratRMSteinINF-[kappa]B functions as a tumour promoter in inflammation-associated cancerNature2004431700746146615329734
   PubMed Web of Science ®Google Scholar
• GretenFREckmannLGretenTFIKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancerCell2004118328529615294155
   PubMed Web of Science ®Google Scholar
• TakadaYBhardwajAPotdarPAggarwalBBNonsteroidal anti-inflammatory agents differ in their ability to suppress NF-[kappa]B activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferationOncogene200423579247925815489888
   PubMed Web of Science ®Google Scholar
• HolmesMDChenWYLiLHertzmarkESpiegelmanDHankinsonSEAspirin intake and survival after breast cancerJ Clin Oncol20102891467147220159825
   PubMed Web of Science ®Google Scholar
• HwangDByrneJScollardDLevineEExpression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancerJ Natl Cancer Inst19989064554609521170
   PubMedGoogle Scholar
• HarrisREBeebe-DonkJAlshafieGAReduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitorsBMC Cancer2006612716445867
   PubMed Web of Science ®Google Scholar
• BorthwickGMJohnsonASPartingtonMBurnJWilsonRArthurHMTherapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanismFASEB J200620122009201617012253
   PubMed Web of Science ®Google Scholar
• ZhangYLiuLFanPAspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancerOncotarget201561299991001525846752
   PubMedGoogle Scholar
• BastiaannetESampieriKDekkersOMUse of Aspirin postdiagnosis improves survival for colon cancer patientsBr J Cancer201210691564157022454078
   PubMed Web of Science ®Google Scholar
• HossainMAKimDHJangJYAspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivoInt J Oncol20124051636164222322725
   PubMed Web of Science ®Google Scholar
• ZhangYLiuLFanPAspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancerOncotarget201561299991001525846752
   PubMedGoogle Scholar
• KisfalviKEiblGSinnett-SmithJRozengurtEMetformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growthCancer Res200969166539654519679549
   PubMed Web of Science ®Google Scholar
• PhillipsPGYalcinMCuiHIncreased tumor uptake of chemotherapeutics and improved chemoresponse by novel non-anticoagulant low molecular weight heparinAnticancer Res201131241141921378319
   PubMed Web of Science ®Google Scholar
• GilmourAMAbdulkhalekSChengTSWA novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancerCell Signal201325122587260323993964
   PubMed Web of Science ®Google Scholar
• JayanthPAmithSRGeeKSzewczukMRNeu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for neurotrophin activation of Trk receptors and cellular signalingCell Signal20102281193120520347965
   PubMed Web of Science ®Google Scholar
• AlghamdiFGuoMAbdulkhalekSCrawfordNAmithSRSzewczukMRA novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetesCell Signal20142661355136824583283
   PubMed Web of Science ®Google Scholar
• HaxhoFAFNeufeldRJSzewczukMRNovel insulin receptor-signaling platformInt J Diabetes Clin Res20141005110
   Google Scholar
• AbdulkhalekSAmithSRFranchukSLNeu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signalingJ Biol Chem201128642365323654921873432
   PubMed Web of Science ®Google Scholar
• AbdulkhalekSGuoMAmithSRJayanthPSzewczukMRG-protein coupled receptor agonists mediate Neu1 sialidase and matrix metalloproteinase-9 cross-talk to induce transactivation of TOLL-like receptors and cellular signalingCell Signal201224112035204222759791
   PubMed Web of Science ®Google Scholar
• AmithSRJayanthPFinlayTDetection of Neu1 sialidase activity in regulating Toll-like receptor activationJ Vis Exp201043
   PubMedGoogle Scholar
• AmithSRSzewczukMRRole of glycosylation in TOLL-like receptor activation and pro-inflammatory responsesWiederschainGGlycobiology and Human DiseasesBoca Raton, FLCRC Press2016165184
   Google Scholar
• AbdulkhalekSSzewczukMRNeu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and -9 activation, cellular signaling and pro-inflammatory responsesCell Signal201325112093210523827939
   PubMed Web of Science ®Google Scholar
• AbdulkhalekSHrynykMSzewczukMRA novel G-protein-coupled receptor-signaling platform and its targeted translation in human diseaseRes Rep Biochem201331730
   Google Scholar
• HaxhoFAllisonSAlghamdiFOseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinomaBreast Cancer: Targets and Therapy20146191203
   PubMedGoogle Scholar